Alume Biosciences, a leading biotechnology company focused on nerve-targeted pharmaceuticals for therapeutic and surgical use, has announced on Friday May 1, 2020 that the company has successfully completed the A funding for the amount of $5.5 million dollars.
According to the details released by the PR Newswire News Agency, The Series A round is expected to completely fund the ALM-488, an intravenously administered peptide for highlighting of nerves during surgery. The compound will further be examined to check the efficacy and safety in different patients undergoing neck and head surgery.
Co-founders Dan Dan Bradbury and Chrysa Mineo also participated in the Series A round.
Founder and Chief Executive Officer of Alume, Quyen Nguyen said, “We had overwhelming interest in our Series A round, which was oversubscribed.”
“I am especially excited and grateful that so many surgeons and physicians representing end-users of the technology participated financially in pursuit of making a nerve illumination agent available in the surgical suite in a rapid timeframe,” Nguyen further added.
Co-founder of Alume, Chrysa Mineo said, “The Alume team has demonstrated exceptional development execution to date, rapidly identifying a lead nerve-illumination candidate after company founding and generating significant interest amongst physicians for the initial indication of head and neck surgery.”
“ALM-488 and related compounds are expected to have broad application across a wide range of surgical indications, reducing operative time for surgeons and most importantly, improving patient outcomes,” Chrysa Mineo further added.
Dan Bradbury said, “It’s not often that you see a Series A round of this size funded primarily by the physicians who will someday use the technology themselves. I saw this groundswell of physician participation and enthusiasm as a very strong signal of the value of the technology when evaluating the company.”
Malik Werner writes related to the Business Category. He manages to cover anything thrown at him owing to his natural inclination towards Business. Malik is our freelance contributor. Malik is responsible for covering developments in finance and business categories.
Email: [email protected]
Address: 11463 East County Road 300 South, Kirklin, IN 46050, USA
Contact number: 765-379-9940